iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.52M
Expense Ratio	0.47%
PE Ratio	n/a
Shares Out	150,000
Dividend (ttm)	$0.01
Dividend Yield	0.06%
Ex-Dividend Date	Dec 20, 2023
Payout Ratio	n/a
1-Year Return	-6.98%

Volume	1
Open	23.32
Previous Close	23.47
Day's Range	22.87 - 23.32
52-Week Low	19.08
52-Week High	26.90
Beta	n/a
Holdings	63
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

44.73% of assets

Name	Symbol	Weight
Intra-Cellular Therapies, Inc.	ITCI	5.06%
Neurocrine Biosciences, Inc.	NBIX	4.79%
Cerevel Therapeutics Holdings, Inc.	CERE	4.78%
Axonics, Inc.	AXNX	4.68%
argenx SE	ARGX	4.39%
Sarepta Therapeutics, Inc.	SRPT	4.33%
Xenon Pharmaceuticals Inc.	XENE	4.20%
Biohaven Pharmaceutical Holding Company Ltd.	BHVN	4.20%
Integra LifeSciences Holdings Corporation	IART	4.19%
Biogen Inc.	BIIB	4.11%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023